CSIMarket Company Name, Ticker, Industry, else..


Infusystem Holdings Inc  (NYSEAMER: INFU)
Other Ticker:  
 

Infusystem Holdings Inc

INFU's Fundamental analysis



Looking into Infusystem Holdings Inc growth rates, revenue grew by 10.69 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 1342

Medical Equipment & Supplies industry recorded growth of revenues by 1.71 %

Infusystem Holdings Inc's net income grew by 162.26 % in III. Quarter 2024 year on year, above company average,

• More on INFU's Growth


Infusystem Holdings Inc
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Infusystem Holdings Inc PEG ratio is at 1.48 Company is currently trading with Price to Cash flow multiple of 773.16 in trailing twelve-month period.
Company
123.78
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.28.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.54.


• More on INFU's Valuation
 
 Total Debt (Millions $) 28
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 381,563
 Net Income/Employee (TTM) $ 4,264
 Receivable Turnover (TTM) 6.29
 Tangible Book Value (Per Share $) 2.08

Infusystem Holdings Inc
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Infusystem Holdings Inc PEG ratio is at 1.48 Company is currently trading with Price to Cash flow multiple of 773.16 in trailing twelve-month period.
Company
123.78
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.28.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.54.

Infusystem Holdings Inc Price to Book Ratio is at 3.05 higher than Industry Avg. of -179.66, and higher than S&P 500 Avg. of 0.01

• More on INFU's Valuation

•  Market Capitalization (Millions $) 169
•  Shares Outstanding (Millions) 22
•  Employees 348
•  Revenues (TTM) (Millions $) 133
•  Net Income (TTM) (Millions $) 1
•  Cash Flow (TTM) (Millions $) 0
•  Capital Exp. (TTM) (Millions $) -1
•  Total Debt (Millions $) 28
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 381,563
•  Net Income/Employee(TTM) $ 4,264
•  Receivable Turnover Ratio (TTM) 6.29
•  Tangible Book Value (Per Share $) 2.08

•  Market Capitalization (Millions $) 169
•  Shares Outstanding (Millions) 22
•  Employees 348
•  Revenues (TTM) (Millions $) 133
•  Net Income (TTM) (Millions $) 1
•  Cash Flow (TTM) (Millions $) 0
•  Capital Exp. (TTM) (Millions $) -1


    INFU's Profitability Comparisons
Infusystem Holdings Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2024 to 9.24 % from 5.5 % in II. Quarter.

Infusystem Holdings Inc net profit margin of 5.12 % is currently ranking no. 49 in Medical Equipment & Supplies industry, ranking no. 154 in Healthcare sector and number 1810 in S&P 500.


Profitability by Segment
Patient Services 65.98 %
Device Solutions 32.27 %
Total 5.12 %



  Ratio
•   Capital Ratio (MRQ) 1.98
•  Total Debt to Equity (MRQ) 0.5
•  Tangible Leverage Ratio (MRQ) 1.1
•  Asset Turnover Ratio (TTM) 1.26
•  Inventory Turnover Ratio (TTM) 10.04



Infusystem Holdings Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2024 to 9.24 % from 5.5 % in II. Quarter.

Infusystem Holdings Inc net profit margin of 5.12 % is currently ranking no. 49 in Medical Equipment & Supplies industry, ranking no. 154 in Healthcare sector and number 1810 in S&P 500.

• More on INFU's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com